The Royal Society of Chemistry (RSC) Chief Executive Dr Robert Parker has welcomed the announcement of £250 million allocation by the Biotechnology and Biological Sciences Research Council (BBSRC) as the first phase of a five year strategic investment programmes.
The RSC chief said it was an important step towards tackling many of the global challenges outlined in Chemistry for Tomorrow’s World: a roadmap for the chemical sciences, adding that chemists will be pivotal figures in many of the institutes and programmes being funded.
The BBSRC investment includes 26 strategic science programmes and 14 key national research capabilities, to be delivered by eight of the UK’s world-leading bioscience research institutes and their university partners.
To complement the crossover in science disciplines highlighted by the announcement, the RSC recently launched its new journal, Biomaterials Science. The journal will feature high-impact research bridging materials science, biology, chemistry and physics. The journal expects to publish the first online articles in the third quarter of 2012.
